Tuberculosis News and Research

Latest Tuberculosis News and Research

New peptide can target specific pathogen without damaging the good bacteria

Drug-resistant bacteria could lead to more deaths than cancer by 2050, according to a report commissioned by the United Kingdom in 2014 and jointly supported by the U.K. government and the Wellcome Trust.

7 Jan 2021

Novel imaging method reveals in vivo localization of antibiotics in infected lung tissues

Researchers at the Francis Crick Institute and the University of Western Australia have developed a new imaging method to see where antibiotics have reached bacteria within tissues.

5 Jan 2021

New effort to support those who fall on the wrong side of global vaccine divide

As SciDev.Net celebrates 20 years of reporting about the impact of science on people in low- and middle-income countries, the need for our work is greater than ever.

4 Jan 2021

Toxic pesticide turned into treatment against antibiotic-resistant bacteria

N-Aryl-C-nitroazoles are an important class of heterocyclic compounds. They are used as pesticides and fungicides. However, these substances could be toxic to humans and cause mutations.

29 Dec 2020

Kobe University and Sysmex conduct joint research on ELISPOT method for identifying COVID-19

Kobe University and Sysmex Corporation have been engaged in joint research on the ELISPOT method, a new blood test for identifying the novel coronavirus disease (COVID-19).

24 Dec 2020

WHO Global TB Program is mobilizing youth to end tuberculosis

Since the global youth movement, 1+1 youth Initiative was launched on World TB Day 2019, followed by the adoption of the Youth Declaration to End TB at the first-ever Global Youth Townhall on ending TB, there has been significant progress over the past year.

24 Dec 2020

Pandemic backlash jeopardizes public health powers, leaders

A series examining how the U.S. public health front lines have been left understaffed and ill-prepared to save us from the coronavirus pandemic.

15 Dec 2020

Texas Biomed to investigate the effects of cannabinoids on HIV-associated neurocognitive disorder

The National Institutes of Health (NIH) awarded Professor Mahesh Mohan, D.V.M., Ph.D., and collaborators more than $3.5 million over five years to investigate the effects of cannabinoids on Human Immunodeficiency Virus (HIV) associated neurocognitive disorder (HAND).

11 Dec 2020

Longer nocturnal respiratory events in OSA patients have an effect on the heart

Longer nocturnal respiratory events in patients with obstructive sleep apnoea (OSA) cause higher immediate heart rate variability, and greater changes in beat-to-beat intervals are associated with reduced daytime alertness, according to new research from the University of Eastern Finland.

10 Dec 2020

WHO highlights leading causes of mortality and morbidity worldwide from 2000 to 2019

Noncommunicable diseases now make up 7 of the world's top 10 causes of death, according to WHO's 2019 Global Health Estimates, published today.

9 Dec 2020

Possible new antibiotic developed for drug-resistant pulmonary pathogen

Scientists from Johns Hopkins University and Medicine have developed a possible new antibiotic for a pathogen that is notoriously resistant to medications and frequently lethal for people with cystic fibrosis and other lung ailments.

8 Dec 2020

WHO declares updates to forthcoming guidance on systematic screening for TB

In a Rapid Communication issued today, the World Health Organization (WHO) is announcing a number of updates to its forthcoming guidance on the systematic screening of tuberculosis (TB) disease.

7 Dec 2020

Vaccination against tuberculosis has influence on the epidemiology of COVID-19

St Petersburg University scientists have analyzed about 100 academic papers and statistics on the incidence of COVID-19 in different countries of the world.

3 Dec 2020

Global solidarity, resilient services to reduce TB deaths among people living with HIV

The theme of this year's World AIDS Day is "Global solidarity, resilient services". At the 2016 UN High-level Meeting on ending AIDS, member states committed to a 75% reduction of TB deaths among people living with HIV by 2020, compared with 2010.

2 Dec 2020

New reviews provide timely updates for scholars, professionals focused on antimicrobial research

The initial chapter of 'Anti-infective Research and Development: Updates on Infection Mechanisms and Treatments' covers the mode of action of natural antimycobacterial compounds such as nordihydroguaiaretic acid, α-mangostin and allicin, as well as antimicrobial peptides and their role in the innate and adaptive immune response leading to the decrease of microbial resistance.

1 Dec 2020

Researchers reveal how SARS-CoV-2 reaches the brain

Using post-mortem tissue samples, a team of researchers from Charité - Universitätsmedizin Berlin have studied the mechanisms by which the novel coronavirus can reach the brains of patients with COVID-19, and how the immune system responds to the virus once it does.

30 Nov 2020

HIV and TB laboratory systems used to scale up COVID-19 testing in Africa

Many countries in resource-limited settings have high HIV, malaria, tuberculosis, hepatitis, and/or sexually transmitted infection (STI) burdens.

30 Nov 2020

UC San Diego chosen to lead an international $28-million grant for HIV/AIDS clinical trials

University of California San Diego Collaborative Clinical Trials Unit has been selected by the National Institutes of Health to lead and administer an international seven-year, $28-million grant for science-driven clinical trials that deliver innovative, efficient results needed to turn the corner on the HIV/AIDS pandemic.

30 Nov 2020

Mollusc-derived compounds potential medicines for COVID-19 and other respiratory diseases

A research team has reviewed the existing literature on compounds derived from molluscs used for treating respiratory diseases.

30 Nov 2020

TDR and WHO develop interactive web-based research toolkit for TB care

TDR, in partnership with the WHO Global Tuberculosis Programme, has developed an interactive web-based toolkit that supports national TB programmes and other partners to conduct implementation research designed to evaluate digital technologies for TB care.

30 Nov 2020

Tuberculosis News and Research

Latest Tuberculosis News and Research

New peptide can target specific pathogen without damaging the good bacteria

Novel imaging method reveals in vivo localization of antibiotics in infected lung tissues

New effort to support those who fall on the wrong side of global vaccine divide

Toxic pesticide turned into treatment against antibiotic-resistant bacteria

Kobe University and Sysmex conduct joint research on ELISPOT method for identifying COVID-19

WHO Global TB Program is mobilizing youth to end tuberculosis

Pandemic backlash jeopardizes public health powers, leaders

Texas Biomed to investigate the effects of cannabinoids on HIV-associated neurocognitive disorder

Longer nocturnal respiratory events in OSA patients have an effect on the heart

WHO highlights leading causes of mortality and morbidity worldwide from 2000 to 2019

Possible new antibiotic developed for drug-resistant pulmonary pathogen

WHO declares updates to forthcoming guidance on systematic screening for TB

Vaccination against tuberculosis has influence on the epidemiology of COVID-19

Global solidarity, resilient services to reduce TB deaths among people living with HIV

New reviews provide timely updates for scholars, professionals focused on antimicrobial research

Researchers reveal how SARS-CoV-2 reaches the brain

HIV and TB laboratory systems used to scale up COVID-19 testing in Africa

UC San Diego chosen to lead an international $28-million grant for HIV/AIDS clinical trials

Mollusc-derived compounds potential medicines for COVID-19 and other respiratory diseases

TDR and WHO develop interactive web-based research toolkit for TB care

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Tuberculosis News and Research

Latest Tuberculosis News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in